FO
ABBV icon

FT Options’s AbbVie ABBV Stock Holding History

FT Options’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$480K Buy
+5,403
New +$411K 0.72% 46
2017
Q1 		– Sell
-19,886
Closed -$1.25M – 279
2016
Q4 		$1.25M Buy
+19,886
New +$1.21M 1.43% 15
2016
Q2 		– Sell
-9,906
Closed -$604K – 341
2016
Q1 		$566K Buy
+9,906
New +$552K 0.59% 35

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

FT Options's ABBV Position: Q3 2017 in Review

FT Options opened a new position in AbbVie (ABBV) in Q3 2017: 5,403 shares worth $480K. The stake represents 0.72% of the portfolio and ranks #46 among its holdings. This is a return to the name: FT Options previously reported a position in ABBV as recently as Q4 2016.

FT Options first reported a position in ABBV in Q1 2016 and has held it in 3 quarters since. The position peaked at $1.25M in Q4 2016. 1,797 funds tracked by Wall St. Rank hold ABBV as of Q3 2017.

  • FT Options held 5,403 shares of AbbVie worth $480K as of Q3 2017.
  • AbbVie was a new FT Options position in Q3 2017.
  • AbbVie made up 0.72% of FT Options's portfolio in Q3 2017, its #46 holding.
  • FT Options first reported a position in AbbVie in Q1 2016 and has held it in 3 quarters since.
  • FT Options's AbbVie position peaked at $1.25M in Q4 2016.
  • 1,797 funds tracked by Wall St. Rank held AbbVie as of Q3 2017.

Based on FT Options's 13F filing for Q3 2017, filed 13 Nov 2017.